Efficacy and safety of moxifloxacin (MFX) vs. clarithromycin (CLR) for the treatment of community-acquired pneumonia (CAP) - Höffken,G.; Meyer,H.P.; Sprenger,K.; Verhoef,L, . (J Antimicrob Chemother, 1999)